Belgium· BE-AMP-SAM505946-00
Zinbryta 150 mg
A daclizumab product containing daclizumab, registered in Belgium by Biogen Idec. The same ATC class is registered in 3 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Daclizumab is registered in 3 of 19 countries.
Countries holding a registration under ATC L04AC01 (daclizumab), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 2 of them publish a price we can compare per daily dose
Daclizumab · ATC L04AC01
3 / 19 countries
- Belgiumprice
- Finlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Daclizumab
- Manufacturer
- Biogen Idec
- Country
- Belgium (BE)
- ATC code
- L04AC01
- ATC class
- Daclizumab
- Defined daily dose
- 5 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb3542818
- be_apb7718943
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Daclizumab in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f7fc6d73-cdd3-4356-a986-26c19d43f69b GET /v1/drugs/f7fc6d73-cdd3-4356-a986-26c19d43f69b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "REVOKED",
"name_en": "Zinbryta 150 mg",
"name_fr": "Zinbryta 150 mg",
"name_nl": "Zinbryta 150 mg",
"amp_code": "SAM505946-00",
"strengths": [
"150.0000"
],
"pack_count": 2,
"substances": [
"Daclizumab"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Daclizumab",
"authorisation_numbers": [
"EU/1/16/1107/003",
"EU/1/16/1107/004"
]
}See everything about daclizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.